Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C27H28N2O4.C6H8O7 |
| Molecular Weight | 636.6457 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 1 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OC(=O)CC(O)(CC(O)=O)C(O)=O.COC1=CC=C(C=C1)C(=C(C2=CC=CC=C2)[N+]([O-])=O)C3=CC=C(OCCN4CCCC4)C=C3
InChI
InChIKey=LHAPNDAERSFWSC-JGUILPGDSA-N
InChI=1S/C27H28N2O4.C6H8O7/c1-32-24-13-9-21(10-14-24)26(27(29(30)31)23-7-3-2-4-8-23)22-11-15-25(16-12-22)33-20-19-28-17-5-6-18-28;7-3(8)1-6(13,5(11)12)2-4(9)10/h2-4,7-16H,5-6,17-20H2,1H3;13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)/b27-26+;
| Molecular Formula | C6H8O7 |
| Molecular Weight | 192.1235 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | C27H28N2O4 |
| Molecular Weight | 444.5222 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 1 |
| Optical Activity | NONE |
Nitromiphene (NIT; CI 628) is a triarylethylene antiestrogen shown to be effective in treatment of experimental breast cancer. Nitromiphene is one of the earliest nonsteroidal selective estrogen receptor modulators (SERMs). It is an anti-estrogen capable to translocate the estrogen receptor to the nucleus and to induce the replenishment of the cytosol receptor. Nitromiphene inhibited the uptake of [3H]-estradiol in rat whole homogenates and isolated cell nuclei tissues and the pituitary, and inhibited estradiol-induced female sexual behavior. Nitromiphene has thus been shown to suppress the growth of chemically induced and ransplantedmammary tumors in rodents. Also, Nitromiphene was shown to have potent, prolonged antiuterotropic effects in immature rats. Nitromiphene has been shown to undergo conversion to demethyl Nitromiphene (CI628M), a phenolic metabolite which had greater affinity for estrogen receptors and greater biological potency in vitro than did Nitromiphene. However, the in vivo antiestrogenic effects of Nitromiphene and demethyl Nitromiphene were similar, possibly due to facile O-demethylation of the former compound after administration.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Sexual preference and feminine and masculine sexual behavior of male rats prenatally exposed to antiandrogen or antiestrogen. | 1995-06 |
|
| Formation of benzophenone and alpha, alpha-diarylacetophenone metabolites of the antiestrogen nitromiphene (CI628) in the presence of rat cecal contents. | 1983-09-12 |
|
| Biological potency and uterine estrogen receptor interactions of the metabolites of the antiestrogens CI628 and U23,469. | 1981-01 |
|
| Anti-oestrogen action: uterine nuclear retention of the CI-628 anti-oestrogen receptor complex in vitro. | 1977-02 |
|
| Effect of subcutaneous vs intraperitoneal administration of an anti-estrogen, CI-628, estradiol-and estradiol benzoate-stimulated lordosis in the ovariectomized rat. | 1976-10 |
|
| Effects of anti-estrogens on testosterone stimulated male sexual behavior and peripheral target tissues in the castrate male rat. | 1975-06 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/856418
Rats: Nitromiphene was injected intraperitoneally 2 h prior to an intravenous injection of [3H]estradiol, and the animals were killed 2 h after the estradiol.
Route of Administration:
Intraperitoneal
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/6391811
Curator's Comment: CI-628 citrate (1.5 ug/ml) significantly inhibited the transformation of rabbit morulae to blastocysts. https://www.ncbi.nlm.nih.gov/pubmed/6230443
Nitromiphene (CI-628) on the morphology and 17 beta-hydroxysteroid dehydrogenase (17 beta-HSD) activity of mouse blastocysts were compared in culture. When Day 4 mouse blastocysts were cultured in Eagle's medium containing 214 ng 3H-estradiol (E2) and CI-628 at 0, 1.5, 3, 6, 12 and 18 ug/ml, shedding of the zona pellucida was prevented by CI-628. The effect of CI-628 on the morphology was dose-dependent: little effects were seen at 1.5 and 3 ug/ml during the first 2 days, but the blastocysts became small, dense and eventually collapsed inside the zona. At 6 ug/ml and higher, the effect was quite pronounced. The earliest change was seen at 10 hours in 12 and 18 ug/ml CI-628 medium when 1/3 of the embryos became dense and smaller.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:53:25 GMT 2025
by
admin
on
Mon Mar 31 17:53:25 GMT 2025
|
| Record UNII |
TN5UQ266RA
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C481
Created by
admin on Mon Mar 31 17:53:25 GMT 2025 , Edited by admin on Mon Mar 31 17:53:25 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID601350519
Created by
admin on Mon Mar 31 17:53:25 GMT 2025 , Edited by admin on Mon Mar 31 17:53:25 GMT 2025
|
PRIMARY | |||
|
22149
Created by
admin on Mon Mar 31 17:53:25 GMT 2025 , Edited by admin on Mon Mar 31 17:53:25 GMT 2025
|
PRIMARY | |||
|
300000055554
Created by
admin on Mon Mar 31 17:53:25 GMT 2025 , Edited by admin on Mon Mar 31 17:53:25 GMT 2025
|
PRIMARY | |||
|
5863-35-4
Created by
admin on Mon Mar 31 17:53:25 GMT 2025 , Edited by admin on Mon Mar 31 17:53:25 GMT 2025
|
PRIMARY | |||
|
CHEMBL2105203
Created by
admin on Mon Mar 31 17:53:25 GMT 2025 , Edited by admin on Mon Mar 31 17:53:25 GMT 2025
|
PRIMARY | |||
|
TN5UQ266RA
Created by
admin on Mon Mar 31 17:53:25 GMT 2025 , Edited by admin on Mon Mar 31 17:53:25 GMT 2025
|
PRIMARY | |||
|
C90721
Created by
admin on Mon Mar 31 17:53:25 GMT 2025 , Edited by admin on Mon Mar 31 17:53:25 GMT 2025
|
PRIMARY | |||
|
110407
Created by
admin on Mon Mar 31 17:53:25 GMT 2025 , Edited by admin on Mon Mar 31 17:53:25 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE | |||
|
|
PARENT -> SALT/SOLVATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |